Litcius/Paper detail

Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis

Linhui Hu, Alice Charwudzi, Qian Li, Weiwei Zhu, Qianshan Tao, Shudao Xiong, Zhimin Zhai

2021Annals of Hematology36 citationsDOI

Topics & Concepts

Meta-analysisInternal medicineHematologyCD19OncologyMedicineBridge (graph theory)CAR T-cell therapyTerm (time)ImmunotherapyChimeric antigen receptorPeripheral bloodQuantum mechanicsPhysicsCancerCAR-T cell therapy research
Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis | Litcius